Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuing or Discontinuing Anti-tumor Necrosis Factor Treatment in Patients With Ulcerative Colitis in Clinical Remission: a Prospective Open Randomized Parallel-group Study

NCT03011268 is registered in ClinicalTrials.gov with Helse Møre og Romsdal HF as lead sponsor.

NCT NCT03011268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03011268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuing or Discontinuing Anti-tumor Necrosis Factor Treatment in Patients With Ulcerative Colitis in Clinical Remission: a Prospective Open Randomized Parallel-group Study
Lead sponsor
Helse Møre og Romsdal HF
Phase
Not applicable
Overall status
Completed
Start date
June 9, 2017
Completion date
January 20, 2025
Enrollment
174 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

colitis,ulcerative